ClinicalTrials.Veeva

Menu

Enteral Formula Tolerance in Pediatric Patients

N

Nestlé

Status

Completed

Conditions

Enteral Nutrition

Treatments

Other: Enteral Formula

Study type

Interventional

Funder types

Industry

Identifiers

NCT02779335
15.09.US.HCN

Details and patient eligibility

About

The purpose of this prospective study seeks to assess ability to achieve enteral feeding goals with standard polymeric enteral formula in a stable, pediatric tube-fed population.

Full description

In this prospective study, a population of stable, tube-fed children will consume a standard polymetric tube feeding formula to assess ability to achieve enteral feeding goals and tolerance outcomes.

Enrollment

22 patients

Sex

All

Ages

1 to 13 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 1 - 13 years of age
  • Currently tolerating enteral feeding
  • Has enteral access
  • Requires enteral tube feeding to provide 90% or more of their nutritional needs (without the use of modular(s)) for at least 9 days
  • Having obtained his/her and/or his/her legal representative's informed consent

Exclusion criteria

  • Condition which contraindicates enteral feeding (i.e. intestinal obstruction)
  • Lack of enteral access
  • Any condition that would contraindicate use of the study product (i.e. need for severe fluid restriction, cow's milk protein allergy, other)
  • Judged to be at risk for poor compliance to the study protocol
  • Lack of informed consent
  • Currently participating in another conflicting clinical trial

Trial design

22 participants in 1 patient group

Enteral formula tube feeding
Other group
Description:
Enteral fed children, ages 1-13, with establish enteral feeding access
Treatment:
Other: Enteral Formula

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems